Sign in

CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

LENZ Therapeutics, Inc.

Sign in to watch
Ticker
LENZ
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844867570
Phone
858-925-7000
Business address
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
Former names
Graphite Bio, Inc.
  1. 424B5 Offering Prospectus
  2. 424B3 Offering Prospectus
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. CORRESP Other Correspondence Between Filers and SEC Staff
  5. UPLOAD Other SEC-generated Letter
  6. UPLOAD Other SEC-generated Letter
  7. 424B3 Offering Prospectus
  8. 424B3 Offering Prospectus
  9. S-3 Offering Registration Statement
  10. S-3 Offering Registration Statement
  11. 424B3 Offering Prospectus
  12. 424B3 Offering Prospectus
  13. 424B3 Offering Prospectus
  14. 424B3 Offering Prospectus
  15. 424B3 Offering Prospectus
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. UPLOAD Other SEC-generated Letter
  18. S-1 Offering Registration Statement
  19. 424B3 Offering Prospectus
  20. 424B3 Offering Prospectus

Page 1 of 3 · 51 filings